Insider Actions for Intellia Therapeutics Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 01/05/2023 |
Laura Sepp-Lorenzino EVP, Chief Scientific Officer |
689 | Disposition at $39.1 per share. | 26,939 |
| 01/05/2023 |
Laura Sepp-Lorenzino EVP, Chief Scientific Officer |
1,641 | Disposition at $38.22 per share. | 62,719 |
| 01/04/2023 |
John M. Leonard President and CEO; Director |
6,673 | Disposition at $37.21 per share. | 248,302 |
| 01/04/2023 |
David Lebwohl EVP, Chief Medical Officer |
2,574 | Disposition at $37.21 per share. | 95,778 |
| 01/04/2023 |
James Basta EVP, General Counsel |
1,138 | Disposition at $37.21 per share. | 42,344 |
| 01/04/2023 |
Laura Sepp-Lorenzino EVP, Chief Scientific Officer |
2,508 | Disposition at $37.21 per share. | 93,322 |
| 01/04/2023 |
Derek Hicks EVP, Chief Business Officer |
1,812 | Disposition at $37.21 per share. | 67,424 |
| 01/04/2023 |
Glenn Goddard EVP, Chief Financial Officer |
2,427 | Disposition at $37.21 per share. | 90,308 |
| 01/04/2023 |
Eliana Clark EVP, Chief Technical Officer |
1,692 | Disposition at $37.21 per share. | 62,959 |
| 01/03/2023 |
Eliana Clark EVP, Chief Technical Officer |
231 | Disposition at $34.48 per share. | 7,964 |
| 01/01/2023 |
John M. Leonard President and CEO; Director |
7,848 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/01/2023 |
David Lebwohl EVP, Chief Medical Officer |
3,187 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/01/2023 |
Laura Sepp-Lorenzino EVP, Chief Scientific Officer |
3,500 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/01/2023 |
Glenn Goddard EVP, Chief Financial Officer |
3,062 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 07/01/2022 |
Eliana Clark EVP, Chief Technical Officer |
105 | Disposition at $51.74 per share. | 5,432 |
| 06/14/2022 |
Fred Ehrenkranz Cohen Director |
5,197 | Award at $0 per share. | 0 |
| 06/14/2022 |
Caroline D. Dorsa Director |
5,197 | Award at $0 per share. | 0 |
| 06/14/2022 |
Georgia Keresty Director |
5,197 | Award at $0 per share. | 0 |
| 06/14/2022 |
Muna Bhanji Director |
2,014 | Award at $0 per share. | 0 |
| 06/14/2022 |
John Francis Crowley Director |
5,197 | Award at $0 per share. | 0 |
| 06/14/2022 |
Jean-Francois B. Formela Director |
5,197 | Award at $0 per share. | 0 |
| 06/14/2022 |
Frank A. G. M. Verwiel Director |
5,197 | Award at $0 per share. | 0 |
| 06/14/2022 |
Jesse L. Goodman Director |
5,197 | Award at $0 per share. | 0 |
| 04/28/2022 |
Muna Bhanji Director |
7,954 | Award at $0 per share. | 0 |
| 03/01/2022 |
John M. Leonard President and CEO; Director |
40,990 | Award at $0 per share. | 0 |
| 03/01/2022 |
David Lebwohl EVP, Chief Medical Officer |
13,816 | Award at $0 per share. | 0 |
| 03/01/2022 |
Glenn Goddard EVP, Chief Financial Officer |
12,720 | Award at $0 per share. | 0 |
| 03/01/2022 |
Eliana Clark EVP, Chief Technical Officer |
10,527 | Award at $0 per share. | 0 |
| 01/03/2022 |
Derek Hicks EVP, Chief Business Officer |
19,118 | Award at $0 per share. | 0 |
| 01/01/2022 |
John M. Leonard President and CEO; Director |
2,493 | Disposition at $112.26 per share. | 279,864 |
| 01/01/2022 |
David Lebwohl EVP, Chief Medical Officer |
1,051 | Disposition at $112.24 per share. | 117,964 |
| 01/01/2022 |
Glenn Goddard EVP, Chief Financial Officer |
1,013 | Disposition at $112.24 per share. | 113,699 |
| 01/01/2022 |
John M. Leonard President and CEO; Director |
7,848 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/01/2022 |
David Lebwohl EVP, Chief Medical Officer |
3,187 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/01/2022 |
Glenn Goddard EVP, Chief Financial Officer |
3,062 | Derivative/Non-derivative trans. at $0 per share. | 0 |
